We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Masimo

Develops and manufactures non-invasive patient monitoring technologies, including medical devices and sensors read more Featured Products: More products

Download Mobile App




Wireless Pulse Oximeter Shares Data with Mobile Devices

By HospiMedica International staff writers
Posted on 16 Aug 2015
Print article
Image: The MightySat Rx fingertip wireless pulse oximeter (Photo courtesy of Masimo).
Image: The MightySat Rx fingertip wireless pulse oximeter (Photo courtesy of Masimo).
An innovative wireless fingertip pulse oximeter enables clinicians to track and trend measurements through smart mobile devices.

The Masimo MightySat Rx Pulse Oximeter provides oxygen saturation (SpO2), pulse rate, Perfusion Index (PI), and Pleth Variability Index (PVI) using Masimo SET measure-through motion and low perfusion pulse oximetry technology. The Bluetooth-enabled device allow clinicians to track and trend up to 12 hours of patient measurements on smart mobile devices, and to share that data via standard comma-separated-value (CSV) files, as well as transfer the data to the Apple (Cupertino, CA, USA) Health app.

The MightySat Rx Pulse Oximeter is intended for adult and pediatric patients, even during motion and low perfusion. Standard features include Signal IQ to assess measurement confidence; a rugged, lightweight design for operation in challenging environments; a long battery life of up to 15 hours with two standard AAA alkaline batteries; and a comfortable design with a silicon finger pad that molds to patients' fingers. The Masimo MightySat Rx Pulse Oximeter is a product of Masimo (Irvine, CA, USA), and has received the European Community CE marking of approval.

“Many clinicians around the world rely on pulse oximetry as the fifth vital sign. To deliver Masimo SET performance in this low-power form factor took some engineering, given the precision of our technology and SET's computationally intensive algorithm," said Joe Kiani, Founder & CEO of Masimo. “We actually dropped the power consumption by nearly two orders of magnitude. But the development effort was worth it, as we expect this technology will empower clinicians and they will no longer have to compromise performance for mobility.”

Conventional pulse oximetry assumes arterial blood is the only blood pulsating at the measurement site. However, during patient motion, venous blood also moves, causing conventional pulse oximetry to under-read since it cannot distinguish between arterial and venous blood. Masimo SET signal processing identifies the venous blood signal, isolates it, and uses adaptive filters to cancel it, extracting the arterial signal in order to report the true arterial oxygen saturation and pulse rate.

Related Links:

Masimo
Apple


Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Critical Care Trolley
CCT-PX

Print article

Channels

Surgical Techniques

view channel
Image: NTT and Olympus have begun the world\'s first joint demonstration experiment of a cloud endoscopy system (Photo courtesy of Olympus)

Cloud Endoscopy System Enables Real-Time Image Processing on the Cloud

Endoscopes, which are flexible tubes inserted into the body's natural openings for internal examination and biopsy collection, are becoming increasingly vital in medical diagnostics. Their minimal invasiveness... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The PATHFAST hs-cTnI-II high-sensitivity troponin assay has been developed for the PATHFAST Biomarker Analyzer (Photo courtesy of Polymedco)

POC Myocardial Infarction Test Delivers Results in 17 Minutes

Chest pain is the second leading cause of emergency department (ED) visits by adults in the United States, generating over 7 million visits annually. In the event of a suspected heart attack, physicians... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.